Stay updated with breaking news from Prosight Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prosight Management LP boosted its position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 133.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 753,528 shares of the company’s stock after acquiring an additional 430,774 shares during the quarter. AbCellera […]
Prosight Management LP lessened its holdings in Cue Biopharma, Inc. (NASDAQ:CUE – Free Report) by 37.4% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,151,855 shares of the company’s stock after selling 688,655 shares during the quarter. Cue Biopharma comprises 1.9% of Prosight Management […]
Prosight Management LP bought a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The firm bought 80,000 shares of the company’s stock, valued at approximately $8,098,000. Neurocrine Biosciences accounts for approximately 3.8% of Prosight Management LP’s investment […]
Prosight Management LP purchased a new position in Teladoc Health, Inc. (NYSE:TDOC – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 45,900 shares of the health services provider’s stock, valued at approximately $1,189,000. Other institutional investors and hedge […]
Prosight Management LP reduced its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 96.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 9,000 shares of the company’s stock after selling 280,335 shares during the period. Prosight Management LP’s holdings in LifeStance […]